Prophylaxis for recurrent infections in HM patients with antibody deficiency consists of first-line antibiotics and when unsuccessful, gammaglobulin replacement therapy (IgRT). Infectious complications are a major cause of morbidity and mortality in B-cell hematological malignancies (HM). In comparison with Mycoplasma pneumoniae infection in an acute bronhopulmonary affection in For M.hominis-infection groupĪverage level of IgG was 9,4☐,45 g/l and for the group with M.pneumoniae infection group -Ĭonclusion: Mycoplasma hominis infection induces a more expressed humoral immune response Group registered a less intensive synthesis - 8,69☐,3 g/l. Responses in children with micoplasma-positive infection were 9,13☐,3 g/l. For M.pneumoniae-infection group theĪverage level of IgM was 1,61☐,082 g/l, and in M.hominis-infection group the level of IgM wasġ,77☐,15 g/l, and it is higher than in the control group (F=1, T=1,04). Is higher than in the control group (1,52☐,07 g/l, p< 0,05).
Elevated serum levels of IgM were found in study group (1,67☐,074 g/l), which With M.pneumoniae infection the average level of IgA was 0,76☐,06 g/l, and in M.hominis infection Results: IgA levels in children with Mycoplasma-positive bronchopulmonary disease wereĠ,76☐,042 g/l and did not differ from levels of IgA in control group (0,71☐,034 g/l). (IgM, IgG) for M.pneumoniae and M.hominis infection, levels of immunoglobulin A, M, G wereĭetermined in serum samples obtained from all 227 children and were tested by using ELISA. Group consisted of 112 children without mycoplasma infection. Method: The study group included 115 children who had mycoplasma infection and the control
Background: Aim of our study was to evaluate the levels of immunoglobulin A, M, G in childrenĭuring an episode of acute lower respiratory tract infection caused by M.pneumonia and
0 kommentar(er)
